Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EEP
1126
DELISTED
Enbridge Energy Partners
EEP
| $11.8M | 0.02% |
620,300
-11,300
| -2% | -$229K |
|
1127
Atmos Energy
ATO
$28.8B
| $11.8M | 0.02% |
149,000
+33,600
| +29% | +$2.58M |
|
1128
Webster Financial
WBS
$12.8B
| $11.8M | 0.02% |
+235,131
| New | +$12.6M |
|
|
ELOS
1129
DELISTED
Syneron Medical Ltd
ELOS
| $11.7M | 0.02% |
1,104,580
-36,861
| -3% | -$357K |
|
|
APFH
1130
DELISTED
AdvancePierre Foods Holdings
APFH
| $11.6M | 0.02% |
+373,199
| New | +$10.8M |
|
|
MIK
1131
DELISTED
Michaels Stores, Inc
MIK
| $11.6M | 0.02% |
519,400
-67,200
| -11% | -$1.41M |
|
|
FCE.A
1132
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $11.6M | 0.02% |
533,400
-134,200
| -20% | -$2.97M |
|
|
FNHC
1133
DELISTED
FedNat Holding Company Common Stock
FNHC
| $11.6M | 0.02% |
666,200
-59,100
| -8% | -$1.13M |
|
|
FCB
1134
DELISTED
FCB Financial Holdings, Inc.
FCB
| $11.6M | 0.02% |
233,952
-212,300
| -48% | -$10.1M |
|
1135
Embotelladora Andina Series B
AKO.B
$4.84B
| $11.6M | 0.02% |
495,100
+22,300
| +5% | +$514K |
|
|
SP
1136
DELISTED
SP Plus Corporation
SP
| $11.6M | 0.02% |
343,100
+70,800
| +26% | +$2.16M |
|
1137
FirstCash
FCFS
$9.32B
| $11.6M | 0.02% |
235,414
-295,600
| -56% | -$13.1M |
|
1138
Trustmark
TRMK
$2.83B
| $11.6M | 0.02% |
363,904
+119,904
| +49% | +$3.97M |
|
|
CORR
1139
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $11.5M | 0.02% |
341,500
+108,471
| +47% | +$3.79M |
|
1140
Ennis
EBF
$558M
| $11.5M | 0.02% |
677,700
+26,100
| +4% | +$434K |
|
|
KATE
1141
DELISTED
Kate Spade & Company
KATE
| $11.4M | 0.02% |
492,700
+13,200
| +3% | +$276K |
|
|
OLP
1142
One Liberty Properties
OLP
$533M
| $11.4M | 0.02% |
488,989
+25,100
| +5% | +$595K |
|
1143
Goodyear
GT
$1.78B
| $11.4M | 0.02% |
+316,600
| New | +$10.8M |
|
1144
Reliance Steel & Aluminium
RS
$21.8B
| $11.4M | 0.02% |
142,212
-12,500
| -8% | -$1.03M |
|
1145
WaFd
WAFD
$2.82B
| $11.4M | 0.02% |
343,500
-96,700
| -22% | -$3.24M |
|
1146
Stoneridge
SRI
$199M
| $11.4M | 0.02% |
626,600
+82,000
| +15% | +$1.44M |
|
1147
Cenovus Energy
CVE
$55.5B
| $11.3M | 0.02% |
1,004,300
+264,500
| +36% | +$3.55M |
|
|
INVN
1148
DELISTED
Invensense Inc
INVN
| $11.3M | 0.02% |
+898,200
| New | +$11.2M |
|
1149
Sally Beauty Holdings
SBH
$1.55B
| $11.3M | 0.02% |
+554,600
| New | +$12.7M |
|
1150
Highwoods Properties
HIW
$3.51B
| $11.3M | 0.02% |
230,400
+100,800
| +78% | +$5.13M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.